Rayonier - RYN Stock Forecast, Price & News

Rayonier's stock was trading at $40.36 at the start of the year. Since then, RYN stock has decreased by 11.8% and is now trading at $35.58.
View the best growth stocks for 2022 here.

Rayonier saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 4,030,000 shares, an increase of 27.9% from the October 31st total of 3,150,000 shares. Based on an average daily volume of 560,300 shares, the short-interest ratio is currently 7.2 days.
View Rayonier's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our RYN earnings forecast.

Rayonier Inc. (NYSE:RYN) released its earnings results on Wednesday, August, 3rd. The real estate investment trust reported $0.16 EPS for the quarter, topping analysts' consensus estimates of $0.15 by $0.01. Rayonier had a net margin of 8.93% and a trailing twelve-month return on equity of 4.20%. During the same period last year, the business posted $0.22 EPS.

Rayonier announced a quarterly dividend on Friday, October 21st. Investors of record on Friday, December 16th will be given a dividend of $0.285 per share on Friday, December 30th. This represents a $1.14 annualized dividend and a dividend yield of 3.20%. The ex-dividend date is Thursday, December 15th.
Read our dividend analysis for RYN.

Rayonier (NYSE:RYN) pays an annual dividend of $1.14 per share and currently has a dividend yield of 3.27%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 203.57%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, RYN will have a dividend payout ratio of 183.87% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for RYN.

31 employees have rated Rayonier Chief Executive Officer David Nunes on Glassdoor.com. David Nunes has an approval rating of 62% among the company's employees. This puts David Nunes in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rayonier investors own include Energy Transfer (ET), AT&T (T), Bank of America (BAC), Weyerhaeuser (WY), Enterprise Products Partners (EPD), Ciena (CIEN), Ford Motor (F), Pfizer (PFE), Apollo Global Management (APO) and Alliance Resource Partners (ARLP).

Rayonier trades on the New York Stock Exchange (NYSE) under the ticker symbol "RYN."

Rayonier's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (14.67%), Price T Rowe Associates Inc. MD (11.31%), BlackRock Inc. (9.08%), Massachusetts Financial Services Co. MA (6.22%), Pictet Asset Management SA (3.39%) and Impax Asset Management Group plc (3.26%). Insiders that own company stock include April J Tice, April J Tice, David L Nunes, Douglas M Long, Mark Mchugh, Mark R Bridwell, Meridee Moore, Shelby L Pyatt and W Rhett Rogers.
View institutional ownership trends.

Shares of RYN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RYN stock can currently be purchased for approximately $35.58.

Rayonier (NYSE:RYN) has a market capitalization of $5.21 billion and generates $1.11 billion in revenue each year. The real estate investment trust earns $152.55 million in net income (profit) each year or $0.56 on an earnings per share basis.

The company employs 406 workers across the globe.

Rayonier's mailing address is 1 RAYONIER WAY, WILDLIGHT FL, 32097. The official website for the company is www.rayonier.com. The real estate investment trust can be reached via phone at (904) 357-9100, via email at investorrelations@rayonier.com, or via fax at 904-357-9101.